Skip to main content
Laurus Labs Limited logo

Laurus Labs Limited — Investor Relations & Filings

Ticker · LAURUSLABS ISIN · INE947Q01028 LEI · 335800S8HO8QRYP3VQ26 BSE.NS Manufacturing
Open in API
Filings indexed 707 across all filing types
Latest filing 2021-07-15 Regulatory Filings
Country IN India
Listing BSE.NS LAURUSLABS

About Laurus Labs Limited

https://www.lauruslabs.com/

Laurus Labs Limited is a research-driven organization focused on the development and manufacturing of active pharmaceutical ingredients (APIs), finished dosage forms (FDF), and specialized synthesis services. The company operates across several key therapeutic areas, including anti-retroviral (ARV), oncology, cardiovascular, and anti-diabetic treatments. Through its contract development and manufacturing organization (CDMO) division, it provides integrated drug development solutions to global partners. The company also maintains a biotechnology segment dedicated to recombinant products. Leveraging advanced research and development capabilities alongside large-scale manufacturing infrastructure, the firm emphasizes process chemistry innovation and cost-efficient production to serve diverse global healthcare markets.

Recent filings

Filing Released Lang Actions
Shareholders meeting
Regulatory Filings
2021-07-15 English
Updates
Regulatory Filings Classification · 100% confidence The document is a confirmation certificate pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. It confirms that no securities were received for dematerialisation during the quarter ended June 2021. The document is a regulatory compliance certificate and does not contain financial statements, management discussion, or any report data. It is a short letter addressed to stock exchanges and does not represent an annual report, interim report, or any other financial or corporate report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements and compliance documents that do not fit other specific categories.
2021-07-07 English
Press Release
Regulatory Filings
2021-07-02 English
Trading Window
Regulatory Filings Classification · 100% confidence The document text is extremely short (63 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, report title, regulatory references, or any other information to classify it as a specific report type. Given the lack of content, the document does not fit any specific filing category and defaults to the fallback category for miscellaneous filings.
2021-06-30 English
Credit Rating
Regulatory Filings
2021-06-24 English
Copy of Newspaper Publication
Regulatory Filings Classification · 85% confidence The document is very short (687 characters) and contains contact information for shareholder e-voting helpdesks, a date, and a signature by the Company Secretary & Compliance Officer. There is no substantive financial data, no detailed report content, and no mention of financial results or management discussion. The presence of shareholder voting helpdesk details and a formal sign-off suggests this is related to shareholder meeting logistics or voting information rather than a full report or announcement of results. Given the short length and nature of the content, it is likely an announcement related to voting or shareholder meeting procedures rather than the meeting materials themselves. However, since it does not explicitly state voting results or detailed AGM materials, and given the fallback rules, the best fit is Regulatory Filings (RNS) as a general announcement or compliance document related to shareholder voting procedures.
2021-06-22 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.